We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

180 hedge funds and large institutions have $757M invested in Filana Therapeutics in 2021 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 70 increasing their positions, 42 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 42

37% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 38

7% more funds holding

Funds holding: 169 → 180 (+11)

3.32% more ownership

Funds ownership: 27.1% → 30.42% (+3.3%)

10% less call options, than puts

Call options by funds: $304M | Put options by funds: $338M

15% less capital invested

Capital invested by funds: $891M → $757M (-$134M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
180
Holders Change
+11
Holders Change %
+6.51%
% of All Funds
3.15%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
52
Increased
70
Reduced
42
Closed
38
Calls
$304M
Puts
$338M
Net Calls
-$33.9M
Net Calls Change
-$72.8M

Top Buyers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
+$24.2M
2
SC
Sculptor Capital
New York
+$19.7M
3
Voloridge Investment Management
Voloridge Investment Management
Florida
+$18.6M
4
Morgan Stanley
Morgan Stanley
New York
+$16M
5
CAC
Cowen and Company
New York
+$14.6M

Top Sellers

Rank Fund Capital Flow
1
BL
Bleichroeder LP
New York
-$32M
2
Citadel Advisors
Citadel Advisors
Florida
-$24.2M
3
Invesco
Invesco
Georgia
-$12.9M
4
Group One Trading
Group One Trading
Illinois
-$11.4M
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$6.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFA
201
Souders Financial Advisors
Ohio
– -$266K -3,116 Closed
LNWWM
202
Laird Norton Wetherby Wealth Management
California
– -$256K -3,000 Closed
HS
203
HighVista Strategies
Massachusetts
– -$212K -2,488 Closed
IC
204
Intersect Capital
California
– -$192K -2,252 Closed
MC
205
Maverick Capital
Texas
– -$140K -1,637 Closed
PWP
206
Personal Wealth Partners
Minnesota
– -$85K -1,000 Closed
TI
207
tru Independence
Oregon
– -$80K -940 Closed
FIA
208
FNY Investment Advisers
New York
– -$78K -921 Closed
NICM
209
Neo Ivy Capital Management
New York
– -$57K -665 Closed
RE
210
RBC Europe
United Kingdom
– -$23.9K -280 Closed
EVM
211
Eaton Vance Management
Massachusetts
– -$8.35K -100 -57%
Federated Hermes
212
Federated Hermes
Pennsylvania
– -$6K -75 Closed
PWM
213
Prentice Wealth Management
New York
– -$3K -30 Closed
TPCW
214
TD Private Client Wealth
New York
– -$598 -7 Closed
EI
215
Ellevest Inc
New York
– +$334 +4 +133%
CHA
216
Carmichael Hill & Associates
Maryland
– +$501 +6 New
5 6 7 8
9

FLNA Hedge Fund Activity: Q3 2021 in Review

180 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2021, worth a combined $757M — down 15% from $891M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new FLNA positions and 38 closed out — a net gain of 14 holders — while 70 added to existing stakes and 42 trimmed.

The largest buyer was Norges Bank, opening a new position worth an estimated $24.2M. The largest seller was Bleichroeder LP, exiting entirely with an estimated $32M sold.

  • 180 institutional investors held Filana Therapeutics (FLNA) as of Q3 2021, up from 169 in Q2 2021.
  • Funds reported $757M of Filana Therapeutics stock for Q3 2021, down 15% quarter-over-quarter.
  • 52 funds opened new Filana Therapeutics positions in Q3 2021 and 38 closed out, a net change of +14 holders.
  • The largest Filana Therapeutics buyer in Q3 2021 was Norges Bank, an estimated $24.2M added.
  • The largest Filana Therapeutics seller in Q3 2021 was Bleichroeder LP, an estimated $32M sold.

Based on aggregated 13F filings for Q3 2021.